GSK3 Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2004	Glycogen synthase kinase 3: a drug target for CNS therapies.	+	-	nl	J Neurochem 89(6):1313-7 (2004)
2	2009	Glycogen synthase kinase 3: more than a namesake.	+	-	nl	Br J Pharmacol 156(6):885-98 (2009)
3	2009	Regulation of protein stability by GSK3 mediated phosphorylation.	+	-	nl	Cell Cycle 8(24):4032-9 (2009)
4	2009	GSK-3beta, a therapeutic target for cardiomyocyte protection.	+	-	nl	Circ J 73(7):1184-92 (2009)
5	2002	Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.	+	-	nl	Circ Res 90(10):1055-63 (2002)
6	2009	Role of glycogen synthase kinase-3beta in cardioprotection.	+	-	nl	Circ Res 104(11):1240-52 (2009)
7	2003	GSK-3: tricks of the trade for a multi-tasking kinase.	+	-	nl	J Cell Sci 116(Pt 7):1175-86 (2003)
8	2009	Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development.	+	-	nl	J Biol Chem 284(15):9643-7 (2009)
9	2010	Significance of SGK1 in the regulation of neuronal function.	+	-	nl	J Physiol 588(Pt 18):3349-54 (2010)
10	2009	Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.	+	-	nl	J Pharmacol Sci 109(2):179-83 (2009)
11	2009	Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury.	+	-	nl	J Pharmacol Sci 109(2):162-7 (2009)
12	2009	Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: targeting the Wnt pathway and transplantation therapy as strategies for retinal repair.	+	-	nl	J Pharmacol Sci 109(2):168-73 (2009)
13	2009	Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.	+	-	nl	J Pharmacol Sci 110(1):14-28 (2009)
14	2010	GSK3beta: role in therapeutic landscape and development of modulators.	+	-	nl	Br J Pharmacol 160(1):1-19 (2010)
15	2008	Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.	+	-	nl	Br J Pharmacol 153 Suppl 1(-):S137-53 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.